| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7723390 | INSTITUT BIOCHIMIQUE | Pharmaceutical formulations for thyroid hormones |
Mar, 2024
(a month ago) | |
Tirosint is owned by Institut Biochimique.
Tirosint contains Levothyroxine Sodium.
Tirosint has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Tirosint are:
- US7723390
Tirosint was authorised for market use on 01 August, 2007.
Tirosint is available in capsule;oral dosage forms.
The generics of Tirosint are possible to be released after 14 March, 2024.
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Market Authorisation Date: 01 August, 2007
Treatment: NA
Dosage: CAPSULE;ORAL
TIROSINT family patents
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7691411 | IBSA | Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
Mar, 2024
(a month ago) | |
| US7723390 | IBSA | Pharmaceutical formulations for thyroid hormones |
Mar, 2024
(a month ago) | |
Tirosint is owned by Ibsa.
Tirosint contains Levothyroxine Sodium.
Tirosint has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Tirosint are:
- US7691411
- US7723390
Tirosint was authorised for market use on 01 August, 2007.
Tirosint is available in capsule;oral dosage forms.
The generics of Tirosint are possible to be released after 14 March, 2024.
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Market Authorisation Date: 01 August, 2007
Treatment: NA
Dosage: CAPSULE;ORAL
TIROSINT family patents